Taro Pharmaceutical Industries Ltd (TARO)
42.17
-0.06
(-0.14%)
USD |
NYSE |
Apr 24, 13:25
Taro Pharmaceutical Industries Cash from Operations (TTM): 142.87M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 142.87M |
| September 30, 2023 | 124.71M |
| June 30, 2023 | 97.56M |
| March 31, 2023 | 31.75M |
| December 31, 2022 | 16.36M |
| September 30, 2022 | -188.34M |
| June 30, 2022 | -260.72M |
| March 31, 2022 | -158.70M |
| December 31, 2021 | -148.90M |
| September 30, 2021 | 85.89M |
| June 30, 2021 | 25.65M |
| March 31, 2021 | 45.77M |
| December 31, 2020 | 44.31M |
| September 30, 2020 | 100.10M |
| June 30, 2020 | 253.11M |
| March 31, 2020 | 271.60M |
| December 31, 2019 | 280.59M |
| September 30, 2019 | 289.42M |
| June 30, 2019 | 323.87M |
| March 31, 2019 | 323.71M |
| December 31, 2018 | 363.02M |
| September 30, 2018 | 342.64M |
| June 30, 2018 | 333.46M |
| March 31, 2018 | 323.69M |
| December 31, 2017 | 342.88M |
| Date | Value |
|---|---|
| September 30, 2017 | 383.56M |
| June 30, 2017 | 454.24M |
| March 31, 2017 | 437.54M |
| December 31, 2016 | 475.87M |
| September 30, 2016 | 458.48M |
| June 30, 2016 | 382.83M |
| March 31, 2016 | 395.13M |
| December 31, 2015 | 453.66M |
| September 30, 2015 | 439.96M |
| June 30, 2015 | 439.32M |
| March 31, 2015 | 406.79M |
| December 31, 2014 | 276.77M |
| September 30, 2014 | 294.12M |
| June 30, 2014 | 328.97M |
| March 31, 2014 | 357.64M |
| December 31, 2013 | 349.27M |
| September 30, 2013 | 326.85M |
| June 30, 2013 | 293.85M |
| March 31, 2013 | 248.65M |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | 181.41M |
| September 30, 2011 | 151.93M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-260.72M
Minimum
Jun 2022
323.87M
Maximum
Jun 2019
72.47M
Average
85.89M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| InspireMD Inc | -16.38M |
| Ayala Pharmaceuticals Inc | -- |
| BiomX Inc | -21.29M |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | -18.47M |